165 related articles for article (PubMed ID: 35837174)
1.
Wen L; Han Z; Li J; Du Y
J Gastrointest Oncol; 2022 Jun; 13(3):1152-1168. PubMed ID: 35837174
[TBL] [Abstract][Full Text] [Related]
2. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
[TBL] [Abstract][Full Text] [Related]
3. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of binding of doxorubicin and a chlorin compound with 22-mer c-Myc G quadruplex.
Shukla A; Kumari S; Sankar M; Nair MS
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130482. PubMed ID: 37821013
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic investigation of the interaction between G-quadruplex of KRAS promoter sequence and three isoquinoline alkaloids.
Wen LN; Xie MX
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():287-296. PubMed ID: 27565766
[TBL] [Abstract][Full Text] [Related]
6. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic studies of Thioflavin-T binding to c-Myc G-quadruplex DNA.
Verma S; Ghuge SA; Ravichandiran V; Ranjan N
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 212():388-395. PubMed ID: 30703662
[TBL] [Abstract][Full Text] [Related]
8. Arene Ru(II) Complexes with Difluorinated Ligands Act as Potential Inducers of S-Phase Arrest via the Stabilization of
Zeng L; Yuan C; Shu J; Qian J; Wu Q; Chen Y; Wu R; Ouyang X; Li Y; Mei W
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335261
[TBL] [Abstract][Full Text] [Related]
9. Exploring the formation and recognition of an important G-quadruplex in a HIF1α promoter and its transcriptional inhibition by a benzo[c]phenanthridine derivative.
Chen H; Long H; Cui X; Zhou J; Xu M; Yuan G
J Am Chem Soc; 2014 Feb; 136(6):2583-91. PubMed ID: 24450937
[TBL] [Abstract][Full Text] [Related]
10. Berberine Molecular Recognition of the Parallel MYC G-Quadruplex in Solution.
Dickerhoff J; Brundridge N; McLuckey SA; Yang D
J Med Chem; 2021 Nov; 64(21):16205-16212. PubMed ID: 34677968
[TBL] [Abstract][Full Text] [Related]
11. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
13. Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action.
Gu HP; Lin S; Xu M; Yu HY; Du XJ; Zhang YY; Yuan G; Gao W
Endocrinology; 2012 Aug; 153(8):3692-700. PubMed ID: 22673230
[TBL] [Abstract][Full Text] [Related]
14. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
[TBL] [Abstract][Full Text] [Related]
15. Recognition of human telomeric G-quadruplex DNA by berberine analogs: effect of substitution at the 9 and 13 positions of the isoquinoline moiety.
Bhowmik D; Fiorillo G; Lombardi P; Kumar GS
J Mol Recognit; 2015 Dec; 28(12):722-30. PubMed ID: 26138009
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study on High Selectivities of Human Telomeric Dimeric G-Quadruplexes by Dimeric G-Quadruplex Binders.
Liao TC; Ma TZ; Liang Z; Zhang XT; Luo CY; Liu L; Zhou CQ
Chemistry; 2018 Oct; 24(59):15840-15851. PubMed ID: 30088300
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
Wang L; Yu Z; Ren S; Song J; Wang J; Du G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603
[TBL] [Abstract][Full Text] [Related]
18. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene.
Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Eur J Med Chem; 2011 May; 46(5):1906-13. PubMed ID: 21392861
[TBL] [Abstract][Full Text] [Related]
19. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure.
Jiang S; Awadasseid A; Narva S; Cao S; Tanaka Y; Wu Y; Fu W; Zhao X; Wei C; Zhang W
Life Sci; 2020 Oct; 258():118252. PubMed ID: 32791149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
